Skip to main content
SpringerLink
Log in
Book cover

Chemotherapy in Neonates and Infants pp 17–76Cite as

Protocols Used in Chemotherapy Treatment of Neonates and Infants

  • Chapter
  • First Online:

  • 387 Accesses

Abstract

The protocols cited here are provided for quick reference, being necessary a full study of each complete protocol before prescribing; the protocols cited here are referenced in the final section of this book. Protocols may vary according to each institution. It is important to know every drug used in the protocol, to take the necessary care, and to perform the necessary examinations to avoid collateral effects and toxicity. The protocols for neonates and infants should be prescribed by an experienced oncopediatric physician—or under his/her constant supervision if they are prescribed by an oncopediatric physician who is not so accustomed to treating neonates and infants—and should be analyzed and handled by a pharmacist with extensive experience in the oncopediatric area. The protocols should also be administered by a nurse who is experienced in the areas of neonatology and oncology. It is essential that the protocols are devised by the institution before they need to be used, so the professionals have time to study and standardize drug brands, procedures for care, and other needs.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Pieters R, Schrappe M, Valsecchi MG, Biondi A, et al. INTERFANT-06: International collaborative treatment protocol for infants under one year with acute lymphoblastic or biphenotypic leukemia. Stichting Kinderoncologie Nederland. 2016. https://www.skion.nl/workspace/uploads/Interfant-06_version16b_1aug2016_stop-Rand_MEC.pdf. Accessed 13 Jan 2017.

  2. Interfant 2006. Stichting Kinderoncologie Nederland. https://www.skion.nl/voor-professionals/behandelrichtlijnen/protocollen/121/interfant-2006. Accessed 13 Jan 2017.

  3. Munõz L, Nomdedéu JF, Villamor N, et al. Acute myeloid leukemia with MLL rearrangements: clinicobiological features, prognostic impact and value of flow cytometry in the detection of residual leukemic cells. Lekemia. 2003;17:76–82.

    Article  Google Scholar 

  4. Grümayer ER, Schmidmeyer W, Panzer S, Gadner H. Toxicity of sequential high-dose ARA-C asparaginase treatment in childhood poor risk leukemia. Blut. 1986;53(4):309–14.

    Article  Google Scholar 

  5. Möricke A, Reiter A, Zimmermann M, et al. Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95. Blood. 2008;111:4477–89.

    Article  Google Scholar 

  6. Schmidt CWP, Menezes FG. Drug therapy and interactions in pediatric oncology: a pocket guide. Switzerland: Springer; 2017.

    Book  Google Scholar 

  7. Busato M, Ceresér KMM, Onsten TGH, Feijó CS, Schostack N. Protocolo mais utilizado no tratamento da leucemia linfocítica aguda na infância em hospitais de Porto Alegre. Ped Mod. 2003;39:432–45.

    Google Scholar 

  8. Masetti R, Vendemini F, Zama D, Biagi C, Pession A, Locatelli F. Acute myeloid leukemia in infants: biology and treatment. Front Pediatr. 2015;3:37.

    Article  Google Scholar 

  9. Pession A, Rondelli R, Basso G, et al. Treatment and long-term results in children with acute myeloid leukaemia treated according to the AIEOP AML protocols. Leukemia. 2005;19(12):2043–53.

    Article  CAS  Google Scholar 

  10. Geyer JR, Sposto R, Jennings M, et al. Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children’s Cancer Group. Pediatric Cancer. http://ascopubs.org/doi/full/10.1200/jco.2005.09.095. Accessed 13 Jul 2017.

  11. Veal GJ, Errington J, Sastry J, et al. Adaptive dosing of anticancer drugs in neonates: facilitating evidence-based dosing regimens. Cancer Chemother Pharmacol. 2016;77:685–92. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819938.

    Article  CAS  Google Scholar 

  12. Veal GJ, Errington J, Hayden J, et al. Carboplatin therapeutic monitoring in preterm and full-term neonates. Eur J Cancer. 2015;51(14):2022–30.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Curitiba, Paraná, Brazil

    Carolina Witchmichen Penteado Schmidt

Authors
  1. Carolina Witchmichen Penteado Schmidt
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Penteado Schmidt, C.W. (2018). Protocols Used in Chemotherapy Treatment of Neonates and Infants. In: Chemotherapy in Neonates and Infants. Springer, Cham. https://doi.org/10.1007/978-3-319-70591-0_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-70591-0_2

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-70590-3

  • Online ISBN: 978-3-319-70591-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation